• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过分选酶和点击化学法开发稳定的肽-主要组织相容性复合体(MHC)

Development of a Stable Peptide-Major Histocompatibility Complex (MHC) via Sortase and Click Chemistry.

作者信息

Uslu Safak C, Lee Uk-Jae, Tavakolpour Soheil, Abousaway Omar, Nili Ali, Bass Lily, Purwar Pragallabh, Lacson Edward, Berland Lea, Kuhnast Adrien, Clark Louise M, Picard Delia, Rakhshandehroo Taha, Mantri Shreya R, Moravej Heydar, Rashidian Mohammad

机构信息

Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, United States.

Medical Scientist Training Program, Hacettepe University Faculty of Medicine, Ankara 06230, Turkey.

出版信息

ACS Pharmacol Transl Sci. 2024 May 24;7(6):1746-1757. doi: 10.1021/acsptsci.3c00268. eCollection 2024 Jun 14.

DOI:10.1021/acsptsci.3c00268
PMID:38898944
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11184609/
Abstract

T cells play a crucial role in antitumor immune responses and the clearance of infected cells. They identify their targets through the binding of T-cell receptors (TCRs) to peptide-major histocompatibility complex (pMHC) molecules present in cancer cells, infected cells, and antigen-presenting cells. This interaction is often weak, requiring multimeric pMHC molecules to enhance the avidity for identifying antigen-specific T cells. Current exchangeable pMHC-I tetramerization methods may overlook TCRs recognizing less stable yet immunogenic peptides. applications targeting antigen-specific T cells demand the genetic synthesis of a pMHC fusion for each unique peptide antigen, which poses a significant challenge. To address these challenges, we developed a sortase and click chemistry-mediated approach for generating stable pMHC molecules. Leveraging sortase technology, we introduced an azide click-handle near the N-terminus of β2m, proximal to the MHC-peptide-binding groove. Simultaneously, the peptide was engineered with a multi glycine linker and a C-terminal alkyne click-handle. Azide-alkyne click reactions efficiently immobilized the peptide onto the MHC molecule, providing a versatile and efficient method for pMHC generation. The resulting peptide-clicked-MHC specifically binds to its cognate TCR and remains stable for over 3 months at 4 °C in the absence of any additional free peptide. The stability of the pMHC and its affinity to cognate TCRs are influenced by the linker's nature and length. Multi glycine linkers outperform poly(ethylene glycol) (PEG) linkers in this regard. This technology expands the toolkit for identifying and targeting antigen-specific T cells, enhancing our understanding of cancer-specific immune responses, and has the potential to streamline the development of personalized immunotherapies.

摘要

T细胞在抗肿瘤免疫反应和清除受感染细胞中发挥着关键作用。它们通过T细胞受体(TCR)与癌细胞、受感染细胞和抗原呈递细胞中存在的肽-主要组织相容性复合体(pMHC)分子结合来识别其靶标。这种相互作用通常较弱,需要多聚体pMHC分子来增强识别抗原特异性T细胞的亲和力。当前可交换的pMHC-I四聚体化方法可能会忽略识别不太稳定但具有免疫原性的肽的TCR。针对抗原特异性T细胞的应用需要针对每种独特的肽抗原进行pMHC融合的基因合成,这带来了重大挑战。为了应对这些挑战,我们开发了一种分选酶和点击化学介导的方法来生成稳定的pMHC分子。利用分选酶技术,我们在β2m的N末端附近、靠近MHC-肽结合槽的位置引入了一个叠氮化物点击手柄。同时,对肽进行工程改造,使其带有多甘氨酸接头和C末端炔烃点击手柄。叠氮化物-炔烃点击反应有效地将肽固定在MHC分子上,为pMHC的生成提供了一种通用且高效的方法。所得的肽点击MHC特异性结合其同源TCR,并且在4°C下在没有任何额外游离肽的情况下可保持稳定超过3个月。pMHC的稳定性及其与同源TCR的亲和力受接头的性质和长度影响。在这方面,多甘氨酸接头优于聚乙二醇(PEG)接头。这项技术扩展了用于识别和靶向抗原特异性T细胞的工具包,增强了我们对癌症特异性免疫反应的理解,并有可能简化个性化免疫疗法的开发。

相似文献

1
Development of a Stable Peptide-Major Histocompatibility Complex (MHC) via Sortase and Click Chemistry.通过分选酶和点击化学法开发稳定的肽-主要组织相容性复合体(MHC)
ACS Pharmacol Transl Sci. 2024 May 24;7(6):1746-1757. doi: 10.1021/acsptsci.3c00268. eCollection 2024 Jun 14.
2
Quantifying conformational changes in the TCR:pMHC-I binding interface.量化TCR:pMHC-I结合界面中的构象变化。
Front Immunol. 2024 Dec 2;15:1491656. doi: 10.3389/fimmu.2024.1491656. eCollection 2024.
3
MPID-T: database for sequence-structure-function information on T-cell receptor/peptide/MHC interactions.MPID-T:T细胞受体/肽/MHC相互作用的序列-结构-功能信息数据库。
Appl Bioinformatics. 2006;5(2):111-4. doi: 10.2165/00822942-200605020-00005.
4
Multi-positive contrastive learning-based cross-attention model for T cell receptor-antigen binding prediction.基于多阳性对比学习的交叉注意力模型用于T细胞受体-抗原结合预测
Comput Methods Programs Biomed. 2025 May 10;268:108797. doi: 10.1016/j.cmpb.2025.108797.
5
Stress-testing the relationship between T cell receptor/peptide-MHC affinity and cross-reactivity using peptide velcro.使用肽搭扣对 T 细胞受体/肽 MHC 亲和力和交叉反应性之间的关系进行压力测试。
Proc Natl Acad Sci U S A. 2018 Jul 31;115(31):E7369-E7378. doi: 10.1073/pnas.1802746115. Epub 2018 Jul 18.
6
Peptide-MHC Binding Reveals Conserved Allosteric Sites in MHC Class I- and Class II-Restricted T Cell Receptors (TCRs).肽-MHC 结合揭示了 MHC I 类和 II 类限制性 T 细胞受体 (TCR) 中的保守变构位点。
J Mol Biol. 2020 Dec 4;432(24):166697. doi: 10.1016/j.jmb.2020.10.031. Epub 2020 Nov 4.
7
A structural-based machine learning method to classify binding affinities between TCR and peptide-MHC complexes.一种基于结构的机器学习方法,用于分类 TCR 与肽-MHC 复合物之间的结合亲和力。
Mol Immunol. 2021 Nov;139:76-86. doi: 10.1016/j.molimm.2021.07.020. Epub 2021 Aug 26.
8
Normalized Synergy Predicts That CD8 Co-Receptor Contribution to T Cell Receptor (TCR) and pMHC Binding Decreases As TCR Affinity Increases in Human Viral-Specific T Cells.标准化协同作用预测,在人类病毒特异性T细胞中,随着T细胞受体(TCR)亲和力的增加,CD8共受体对TCR和肽段-MHC复合物(pMHC)结合的贡献会降低。
Front Immunol. 2017 Jul 28;8:894. doi: 10.3389/fimmu.2017.00894. eCollection 2017.
9
The T-Cell Receptor Can Bind to the Peptide-Bound Major Histocompatibility Complex and Uncomplexed β-Microglobulin through Distinct Binding Sites.T细胞受体可通过不同的结合位点与肽结合的主要组织相容性复合体及未复合的β-微球蛋白结合。
Biochemistry. 2017 Aug 1;56(30):3945-3961. doi: 10.1021/acs.biochem.7b00385. Epub 2017 Jul 19.
10
T-cell receptor (TCR)-peptide specificity overrides affinity-enhancing TCR-major histocompatibility complex interactions.T细胞受体(TCR)-肽特异性超越了增强亲和力的TCR-主要组织相容性复合体相互作用。
J Biol Chem. 2014 Jan 10;289(2):628-38. doi: 10.1074/jbc.M113.522110. Epub 2013 Nov 6.

本文引用的文献

1
Light-Triggered In Situ Biosynthesis of Artificial Melanin for Skin Protection.光触发原位合成用于皮肤保护的人工黑色素。
Adv Sci (Weinh). 2022 Mar;9(7):e2103503. doi: 10.1002/advs.202103503. Epub 2022 Jan 5.
2
Direct N- or C-Terminal Protein Labeling Via a Sortase-Mediated Swapping Approach.通过一种依赖于 sortase 的交换方法实现直接的 N-或 C-末端蛋白标记。
Bioconjug Chem. 2021 Nov 17;32(11):2397-2406. doi: 10.1021/acs.bioconjchem.1c00442. Epub 2021 Nov 8.
3
T cell receptor-targeted immunotherapeutics drive selective in vivo HIV- and CMV-specific T cell expansion in humanized mice.T 细胞受体靶向免疫疗法在人源化小鼠中驱动体内 HIV 和 CMV 特异性 T 细胞的选择性扩增。
J Clin Invest. 2021 Dec 1;131(23). doi: 10.1172/JCI141051.
4
Checkpoint blockade toxicities: Insights into autoimmunity and treatment.免疫检查点抑制剂毒性:自身免疫与治疗的新视角
Semin Immunol. 2021 Feb;52:101473. doi: 10.1016/j.smim.2021.101473. Epub 2021 Mar 14.
5
Advances in the development of personalized neoantigen-based therapeutic cancer vaccines.基于个性化新抗原的治疗性癌症疫苗的开发进展。
Nat Rev Clin Oncol. 2021 Apr;18(4):215-229. doi: 10.1038/s41571-020-00460-2. Epub 2021 Jan 20.
6
A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer.一项个体化新抗原治疗联合抗 PD-1 治疗晚期黑色素瘤、非小细胞肺癌或膀胱癌患者的 Ib 期临床试验。
Cell. 2020 Oct 15;183(2):347-362.e24. doi: 10.1016/j.cell.2020.08.053.
7
In vivo detection of antigen-specific CD8 T cells by immuno-positron emission tomography.免疫正电子发射断层扫描术检测抗原特异性 CD8 T 细胞。
Nat Methods. 2020 Oct;17(10):1025-1032. doi: 10.1038/s41592-020-0934-5. Epub 2020 Sep 14.
8
CUE-101, a Novel E7-pHLA-IL2-Fc Fusion Protein, Enhances Tumor Antigen-Specific T-Cell Activation for the Treatment of HPV16-Driven Malignancies.CUE-101,一种新型的 E7-pHLA-IL2-Fc 融合蛋白,增强了肿瘤抗原特异性 T 细胞的激活,用于治疗 HPV16 驱动的恶性肿瘤。
Clin Cancer Res. 2020 Apr 15;26(8):1953-1964. doi: 10.1158/1078-0432.CCR-19-3354. Epub 2020 Jan 21.
9
Targeting cancers through TCR-peptide/MHC interactions.通过 TCR-肽/MHC 相互作用靶向癌症。
J Hematol Oncol. 2019 Dec 18;12(1):139. doi: 10.1186/s13045-019-0812-8.
10
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.纳武利尤单抗联合伊匹木单抗治疗晚期黑色素瘤的 5 年生存数据
N Engl J Med. 2019 Oct 17;381(16):1535-1546. doi: 10.1056/NEJMoa1910836. Epub 2019 Sep 28.